DZG Innovation Fund: Cell type specific targeting for future in vivo delivery in cell and gene therapy
| Institution | Universität Heidelberg |
|---|---|
| Project leader | Johannes Backs |
| Site | Heidelberg/Mannheim |
| Project type | DZG Innovation Cluster |
| Funding | € 70.333,32 |
| Begin | 01.01.2023 |
| End | 31.01.2025 |
Förderkennzeichen
81X4500111
Projektnummer
1636